Showing 1 - 1 results of 1 for search '"il-6/jak/stat3"', query time: 0.03s Refine Results
  1. 1
    Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages

    Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages by Yuan Li, Yanping Chen, Yuan Meng, Meng Shen, Fan Yang, Xiubao Ren

    Published 2024-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: